Because price and margin headwinds exist predominantly in small-molecule oral tablets that are easy to produce, we expect Viatris’ pipeline to focus more on complex generics—drugs that have complex ...

Meanwhile, actual health experts reacted to the news with alarm and devastation, given that cancelling the contracts hurts ...

Accelerating overseas growth of the food business is high on the agenda. Meiji’s lack of overseas exposure, specifically in the food business, has become an obvious drawback amid rapid inflation and ...

The health secretary has halted the development of 22 mRNA vaccine projects by BARDA while stopping all future schemes.

The Trump administration is terminating 22 contracts focused on developing mRNA vaccines and winding down additional federal investments in mRNA technology, Health and Human Services Secretary Robert ...

Driven by lessons from the pandemic and a reliance on imports -- more than $2.16 billion in packaged medicines in 2023, most ...

Learn more about whether Amneal Pharmaceuticals, Inc. or Ocular Therapeutix, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Major Vietnamese drugmakers, including DHG Pharma, Traphaco, and Imexpharm, posted profit gains in Q2 and H1/2025 from a year ...

The impact on innovator contract research, development and manufacturing organisations (CRDMOs) would be relatively lower ...

Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...

With one year until new rules on ‘high-risk’ AI systems take effect in the EU, pharmaceutical companies using AI in the ...

Thermo Fisher shows signs of post-COVID recovery, but modest growth, valuation risks, and macro pressures warrant caution.